1. Introduction {#sec0001}
===============

Attention deficit hyperactivity disorder (ADHD) is defined by behavioral symptoms of inattention, hyperactivity and impulsivity; troubling approximately 5% of children and 2.5% of adults ([@bib0002]; [@bib0057]; [@bib0076]). While ADHD tends to manifest in a range of symptoms, it is thought that deficient response inhibition - reduced ability to suppress inadequate but prepotent response tendencies - is one of the central dysfunctions characterizing the disorder ([@bib0007]; [@bib0052]; [@bib0090]). The most common paradigms used to study response inhibition are Go/No-go and Stop-Signal tasks ([@bib0060]) where poor inhibitory control is behaviorally reflected in high rate of commission errors (i.e. false alarms) in Go/No-go tasks and in long stop-signal reaction time (SSRT) in Stop-Signal tasks (i.e. it takes longer to cancel an ongoing response). It has been consistently demonstrated that response inhibition, as assessed with these tasks, is deficient both in children and in adults with ADHD ([@bib0033]; [@bib0042]; [@bib0086]; [@bib0090]).

In contrast with the consistent behavioral effects, previous attempts to uncover the underlying brain mechanism that contributes to impaired response inhibition in ADHD patients have produced mixed results. Findings from functional magnetic resonance imaging (fMRI) studies of ADHD participants (predominantly children) using Go/No-go and Stop-Signal tasks suggest disrupted activation of a right-lateralized fronto-striatal network implicated in response inhibition (see meta-analyses in [@bib0020]; [@bib0032]; [@bib0043]). However, in studies of adults with ADHD, results are much more inconsistent, and the nature of neural disruption is unclear. As summarized by Congdon and colleagues ([@bib0019]), some studies report hypoactivation in ADHD relative to neurotypicals ([@bib0023]; [@bib0046]; [@bib0050]; [@bib0071]), while other report hyperactivation in ADHD ([@bib0027]; [@bib0036]), or no difference between patients and neurotypicals ([@bib0011]; [@bib0019]). The problem is exacerbated by the tendency of studies to report an extensive (and sometimes varied) network of regions associated with inhibition, including inferior frontal cortex, the insula, pre-supplementary motor area, medial-superior frontal gyrus, cingulate cortex, the striatum and thalamus. It is therefore possible that a coherent picture will emerge if a more specific set of brain regions can be identified in respect to response inhibition.

In a recent study with neurotypical adults ([@bib0040]), we utilized a unique experimental design of a Go/No-go task to increase the specificity of inhibition-related activation. We manipulated the ratio of Go and No-go stimuli, to create two variants of the task: rare-No-go and prevalent-No-go ([Fig. 1](#fig0001){ref-type="fig"}). While inhibition is required in all No-go trials, a rare-No-go version (only 25% of trials are No-go) yields a tendency to respond in every trial and hence a strong demand for inhibition is posed when a No-go stimulus appears, whereas a prevalent-No-go version (75% of all trials are No-go) requires very little inhibition effort. Thus, contrasting No-go trials from these different contexts pinpoints inhibition-related brain activation. This design is different from common Go/No-go and Stop-signal task designs that compare No-go/Stop trials with Go trials, which therefore capture various differences between the trial types in addition to response inhibition -- visual properties, stimulus processing, motor planning and execution. Conversely, directly contrasting between No-go trials (rare vs. prevalent), enables isolating inhibition-related activation while eliminating contaminating motor and visual factors. In our previous study including a sample of neurotypical adults, this approach has been successful in identifying specific inhibition-related activation in the intraparietal sulcus (IPS) and in the left temporo-parietal junction (TPJ) ([@bib0040]). Crucially, activity in these regions did not show any differences between rare- and prevalent-Go trials, indicating that their activation is not attributable to general processes of saliency detection, attentional capture or expectancy, but is specifically related to inhibition associated with the No-go trials.Fig. 1Experimental design. Illustration of the Go/No-go task, in which participants were shown a series of stimuli. Participants were instructed to respond quickly when a Go stimulus - a red square - was presented in the center of a screen, and to withhold response to all other stimuli. Trials occurred in a randomized order within two types of runs: A) Rare-No-go (25% No-go stimuli and 75% Go stimuli) and B) Prevalent-No-go (75% No-go stimuli and 25% Go stimuli). See *Methods*[Section 2.3](#sec0005){ref-type="sec"} and *Supplementary Materials* Section S for a full description of the task.Fig. 1

The specificity achieved by such a task design in identifying response inhibition processes in the brain is particularly relevant in the context of ADHD, which has been also associated with a variety of other (non response-inhibition) impairments, including sustained attention ([@bib0033]; [@bib0082]), response selection ([@bib0049]; [@bib0072]), and temporal processing ([@bib0025]; [@bib0077]). These, among others, may play a role in Go/No-go tasks, and are likely to alter the processing and performance of both trial types (Go and No-go). Thus, when investigating response inhibition in ADHD, isolating inhibition-related activation from other cognitive processes occurring throughout the task, may prove critical.

In the current study, we examine inhibition-related brain activation among adults with ADHD, as measured in a Go/No-go task by contrasting rare-No-go trials against prevalent-No-go trials, using a whole-brain approach as well as ROI analyses in the IPS and TPJ. Furthermore, we investigate whether the extent of inhibition-related activation is related to the severity of ADHD symptoms. Such examination of individual differences in symptoms and in brain function has the benefit of accommodating the considerable heterogeneity in ADHD ([@bib0039]; [@bib0054]), and also provides evidence for the potential clinical significance of abnormal inhibition-related brain activation. Finally, we assess whether altered engagement of the parietal cortex in inhibition is accompanied by altered fronto-parietal connectivity using generalized context-dependent psychophysical interactions (gPPI). Such an analysis may point to possible mechanisms underlying an impaired IPS modulation in response inhibition in ADHD.

2. Methods and Materials {#sec0002}
========================

2.1. Participants {#sec0003}
-----------------

Forty-eight adults with ADHD participated in the study. 11 were excluded due to various reasons, described in detail in the Supplementary Materials [Section 1](#sec0001){ref-type="sec"} (e.g., abnormal neurological findings, scanner artifacts, excessive motion). Thus, the final sample included 37 participants, 15 men and 22 women, aged between 19 and 34 (mean age = 26.6, SD = 4.0). Participants were recruited through advertisement within university and college campuses. All had a previous diagnosis of ADHD by a qualified clinician, and each participant also completed a full psychiatric evaluation conducted by ST -- a certified psychiatrist, which included psychiatric history and mental status examination according to DSM-5 ([@bib0002]) criteria. Participants were excluded if they had neurological or psychiatric disorders other than ADHD, including major depression, anxiety, OCD, or psychosis. All participants met criteria for current diagnosis of ADHD and were not using any psychotropic medications other than psychostimulants customary to treat ADHD, and those receiving psychostimulants (11 participants on a regular basis, 20 participants irregularly taking the medicine) had at least 24-hours washout period before each testing session. All had normal or corrected-to-normal vision (glasses were replaced in the scanner with MRI-compatible goggles). Participants had no contraindication to MRI scanning. The study conformed to the Declaration of Helsinki and was approved by the ethics committees of Sheeba medical center and of Tel-Aviv University in Israel. All participants provided written informed consent after receiving a complete description of the study.

2.2. Symptom severity {#sec0004}
---------------------

ADHD current symptom severity was scored using the Hebrew version of the Adult ADHD Self-Report Scale (ASRS) ([@bib0037]; [@bib0091]). The ASRS is comprised of 18 items corresponding to the DSM diagnostic criteria. For each item, participants indicate how well the symptom describes them currently, on a Likert scale (1=not at all, 5=to a large extent). The total score (overall sum) of the ASRS gives an estimate of a participants' current symptom severity. The possible range of scores is from 18 to 90.

2.3. Go/No-go task {#sec0005}
------------------

The Go/No-go task ([@bib0040]) consisted of a stream of colored shapes, appearing one by one in the center of the screen. Each shape appeared for 100 msec, with varying inter stimulus intervals ([Fig. 1](#fig0001){ref-type="fig"}). Participants were instructed to respond quickly when a Go stimulus - a red square - was presented, and to withhold response to all other stimuli. We are mostly interested in No-go trials, where participants must withhold their response. The task included two variants: rare-No-go and prevalent-No-go. In the rare-No-go condition, 75% of trials were Go trials and only 25% were No-go trials. In this case, participants are required to respond in the majority of trials, and thus it is difficult to withhold a response in the presence of rare No-go trials. In the prevalent-No-go condition the ratio is inverted -- 25% of trials are Go trials and 75% are No-go trials. In this condition, there is no bias to respond; hence the need for inhibition is greatly reduced. A complete description of the task can be found in the Supplementary Materials [Section 2](#sec0002){ref-type="sec"}.

2.4. Experimental procedure {#sec0006}
---------------------------

In order to get familiar with the task prior to the fMRI session, participants attended the lab on a separate day and performed the Go/No-go task in a regular lab setting. During the fMRI scan, participants performed 4 blocks of the task: two of rare-No-go and two of prevalent-No-go, interspersed by an anatomical T1-weighted scan. The order of block types (rare- and prevalent-No-go) was counterbalanced across participants. The stimuli were projected onto a screen and viewed by a mirror mounted on the head coil. Responses were collected via an MRI-compatible response box. Additional scans were acquired after completion of the experimental functional runs, and are not further described in the current paper. The total period of time in the scanner was approximately 60 minutes.

2.5. Behavioral data analysis {#sec0007}
-----------------------------

Paired t-tests were computed to compare performance in the rare-No-go and prevalent-No-go conditions, in measures of mean reaction time (RT), standard deviation of RT, omission and commission errors. False Discovery Rate (FDR) was applied to correct for multiple comparisons. Effect sizes were estimated by Cohen\'s d for paired t-tests, adjusted to correct for dependence among means ([@bib0048]).

2.6. fMRI analysis {#sec0008}
------------------

fMRI data processing was carried out using FSL (FMRIB\'s Software Library, [www.fmrib.ox.ac.uk/fsl](http://www.fmrib.ox.ac.uk/fsl){#interref0001}), version 5.0 ([@bib0034]). fMRI acquisition parameters and preprocessing steps are described in detail in the Supplementary Materials [Sections 3](#sec0010){ref-type="sec"} and [4](#sec0017){ref-type="sec"}. Time-series statistical analysis was carried out using FILM with local autocorrelation correction ([@bib0089]). Standard GLM fitting was conducted for all subjects. The following events were modeled using a boxcar regressor convolved with a canonical double gamma hemodynamic response function: correct Go, correct No-go, omissions, and commission errors. Null events were not modeled and therefore constitute an implicit baseline. Events were modeled at the time of stimulus onset with duration of 0.1 s. The six motion parameters and temporal derivatives of all regressors were included as covariates of no interest to improve statistical sensitivity. Volumes with framewise displacement (FD) \> 0.9 were flagged and regressed out ("motion scrubbing", [@bib0075]; see more details in the *Supplementary Materials* Section 5). Results from a contrast of correct No-go trials (i.e. successful inhibitions) versus baseline were fed into the second level analysis. The second level analysis, combining runs within subject, was carried out using a fixed effects model, by forcing the random effects variance to zero in FLAME (FMRIB\'s Local Analysis of Mixed Effects) ([@bib0008]; [@bib0087]; [@bib0088]). In order to isolate inhibition-specific activation, a *rare-No-go minus prevalent-No-go* contrast was computed for each subject. As described above, response inhibition is highly challenging in the rare-No-go, but substantially less so in the prevalent-No-go. Hence the contrast between No-go events in the two conditions reflects the inhibitory process. To control for potential confounds of saliency and expectancy in the abovementioned main contrast, we also computed a *rare-Go minus prevalent-Go* contrast.

Group analysis was carried out using FLAME (FMRIB\'s Local Analysis of Mixed Effects) stage 1 ([@bib0008]; [@bib0087]; [@bib0088]). Z (Gaussianised T/F) statistic images were thresholded using clusters determined by Z\>2.3 and a (corrected) cluster significance threshold of *P*=0.05 ([@bib0089]), corrected for multiple comparisons using Gaussian random field theory. Activation clusters are reported in MNI coordinates, using Cluster command in FSL. For visualization of results, statistical maps were projected onto an average cortical surface with the use of multifiducial mapping using CARET software ([@bib0083]) (<http://brainvis.wustl.edu/wiki/index.php/Caret:Download>).

ROI analysis was conducted using masks of inhibition-related activation in neurotypical adults (masks are available online linked to ([@bib0040])). Percent signal change for each condition (rare-No-go and prevalent-No-go) was computed in reference to an implicit baseline and averaged across voxels within each cluster. Comparison of the resulting values between conditions was conducted using paired t-tests, and further complemented with Bayesian statistics to quantify the support for the null hypothesis (see details in the Supplementary Materials Section 6).

In order to test the effect of symptom severity, a whole-brain regression analysis was conducted at the group level, including demeaned symptom severity scores as a covariate of interest. This allowed for investigation of the relationship between inhibition-related activation, as reflected in the difference between rare-No-go and prevalent-No-go activation, and current symptom severity.

In order to visualize the latter, we extracted percent signal change values for each condition (rare-No-go and prevalent-No-go). Percent signal change was computed in reference to an implicit baseline in clusters from group level analyses, and in intersection masks of current group level analysis with ROI masks of parietal inhibition-related activation in neurotypicals. Percent signal change is plotted against symptom severity scores for visualization only, with no inferential statistics, to avoid circular analysis and inflated correlation values ([@bib0059]; [@bib0084]).

Three separate Follow-up analyses investigated effects of age, sex and usage of psychostimulant medication. We compared inhibition-related activation between male and female participants; and between participants who are treated regularly with psychostimulants vs. participants using the medication sporadically (only 6 participants were not using any psychostimulants, and these were excluded from this analysis). Finally, we investigated the effect of age on inhibition-related activation by including age as a covariate in the model.

2.7. Functional connectivity analysis: psychophysical interactions {#sec0009}
------------------------------------------------------------------

Three generalized psychophysical interaction analyses (gPPI; [@bib0044]), were conducted to examine differential task-based functional connectivity between seed regions derived from the main analysis and other regions of the brain. The three selected seed regions were located in the IPS (two clusters in the left IPS and one cluster in the right IPS), defined from the intersection of the whole-brain analysis result of symptom severity effects with the pre-defined ROIs described above (depicted in [Fig. 2](#fig0002){ref-type="fig"}B). For each seed region, the seed mask was projected back to the native space of each participant, and an averaged timeseries was extracted from the preprocessed fMRI data. A standard GLM was ran for each run as described for the main analysis, with the addition of gPPI interaction terms, created by multiplying the task regressors (Go and No-go events) with the seed ROI timecourse, and creating a contrast of rare-No-go trials with prevalent-No-go trials. In the group level analysis, demeaned ASRS scores were entered as a covariate of interest, to allow investigation of how functional connectivity patterns of the IPS are modulated by the task demands as well as by individual differences in ADHD symptom severity.Fig. 2(A) Regions where inhibition-related activation is negatively correlated with ADHD symptom severity. See [Table 2](#tbl0002){ref-type="table"} for detailed cluster information. The statistical map is corrected for whole-brain multiple comparisons and projected onto an average cortical surface using CARET (R = Right). The color bar represents the z-score. (B) Regions of overlap between pre-defined regions of interest and [Fig. 2](#fig0002){ref-type="fig"}A; i.e. regions identified in neurotypicals as inhibition-related that also demonstrate correlation with symptom severity in adults with ADHD. (C) Scatter plots visualizing the correlation in these regions among ADHD participants: inhibition-related activation as a function of ADHD symptom severity. Inhibition-related activation quantified as difference in % signal change between rare- and prevalent-No-go, averaged across voxels in the clusters presented in B.Fig. 2

3. Results {#sec0010}
==========

3.1. Behavioral results {#sec0011}
-----------------------

Behavioral data were examined using paired sampled t-tests comparing the rare-No-Go condition to the prevalent-No-Go condition, in order to assure the experimental manipulation. As expected, and as was previously demonstrated with neurotypicals, RTs for Go trials were significantly faster in the rare-No-go condition (*M* = 524 msec, SD = 77) than in the prevalent-No-go condition (*M* = 586 msec, SD = 79; t(36) = 13.0, *p*\<.001, Cohen\'s d = 2.13), reflecting the tendency to respond quickly that was created in the rare-No-go condition. Critically, commission errors occurred more frequently in the rare-No-go condition (M = 7.6%, SD = 5.7) than in the prevalent-No-go condition (*M* = 1.0%, SD = 1.2; t(36)=7.8, *p*\<.001, Cohen\'s d = 2.04). This demonstrates that the inhibition was indeed more demanding in the rare-No-go condition. Standard deviation of RT and rate of omission errors did not differ between conditions (SDRT: *M* = 82.3 (SD = 34.2) vs. *M* = 81.9 (SD = 34.3) msec; omissions: M = 3.3% (SD = 4.4) vs M = 4.3% (SD = 6.4), in the rare-No-go and the prevalent-No-go, respectively; t\'s \< 2, n.s.), indicating similar levels of sustained attention ([@bib0035]; [@bib0073]).

3.2. fMRI results {#sec0012}
-----------------

### 3.2.1. Inhibition-related activation {#sec0013}

In order to isolate brain activation which is uniquely associated with inhibition we used the contrast of No-go trials from the two different occurrence rates: the activity in prevalent-No-go trials was subtracted from the activity in rare-No-go trials. This contrast yielded no clusters of activation, i.e. neural activity across the brain in response to No-go stimuli was comparable regardless of the inhibitory demand.

To further examine this we employed regions of interest (ROIs) approach, specifically looking into activation in the right and left IPS and in the left TPJ, previously reported to be modulated by inhibitory demand in this task ([@bib0040]). Paired t-tests comparing percent signal change calculated within those ROIs, for rare-No-go and for prevalent-No-go, revealed no significant differences in the extent of activation between conditions, in any of the ROIs. Furthermore, Bayesian analysis provided conclusive evidence in favor of the null hypothesis, i.e., no difference between conditions ([Table 1](#tbl0001){ref-type="table"}). This emphasizes the null results of the whole-brain analysis, showing that for adults with ADHD there is no difference between activation in rare-No-go trials and activation in prevalent-No-go trials.Table 1Lack of parietal modulation in response inhibition among ADHD participants.Table 1Brain region% signal change Rare-No-go Mean (SD)% signal change Prevalent-No-go Mean (SD)Paired-t statistic df = 37BF~null~Right IPS0.09 (0.20)0.04 (0.14)1.24 *^n.s.^*2.83Posterior Left IPS0.07 (0.27)0.11 (0.19)-0.74 *^n.s.^*4.44Left TPJ and anterior IPS0.07 (0.16)0.06 (0.13)0.22 *^n.s.^*5.59[^1]

To examine the possibility that the data is noisy, hence rendering any effect difficult to detect, we re-analyzed the data in the traditional approach, contrasting No-go trials with Go-trials in the rare-No-go condition. The activation map revealed occipital and parietal regions, in line with the broad literature on Go/No-go tasks ([@bib0021]; [@bib0080]) and matching closely with the pattern of activation reported in neurotypicals using the same task design ([@bib0040]). Frontal regions showed only modest responses, which is also in line with existing ADHD literature (e.g. [@bib0019]; [@bib0047]; see detailed results in the Supplementary Materials Section 7). These findings rule out the possibility that the absence of specific inhibition-related activation is the result of noisy data. Furthermore, we performed another control analysis contrasting rare-Go trials with prevalent-Go trials. This analysis yielded large distributed activation throughout the brain (see detailed results in the Supplementary Materials Section 8), including in parietal cortex, demonstrating sensitivity to stimulus frequency. This indicates that the absence of response in the main contrast of rare vs. prevalent-No-go trials is specific to No-go stimuli, hence does not reflect overall insensitivity to statistical regularities, and is presumably reflecting insensitivity to the associated inhibitory demand.

### 3.2.2. Effect of symptom severity {#sec0014}

In order to examine the relationship between inhibition-related activation and severity of ADHD symptoms, we added individuals' ASRS questionnaire scores as a covariate to the GLM, testing for interaction with the difference in activation between rare-No-go and prevalent-No-go, which quantifies inhibition-related neural activity. Interestingly, symptom severity was negatively correlated with such difference in activation in multiple fronto-parietal regions ([Fig. 2](#fig0002){ref-type="fig"}A and [Table 2](#tbl0002){ref-type="table"}). Importantly, these include left and right IPS, identified in neurotypicals as involved in response inhibition. This means that participants with ADHD experiencing relatively mild symptom severity demonstrate a pattern of parietal inhibition-related activation that is similar to that found in neurotypicals: higher activation in the IPS towards rare-No-go stimuli than to prevalent-No-go stimuli, i.e., higher activation when inhibition is difficult and demanding. On the other hand, participants who report more severe behavioral manifestation of ADHD show no difference in parietal activation between conditions with different inhibitory demand, or even show a reverse pattern of activation, where IPS is less activated when the demand for inhibition is high. For visualization of this relation between brain activation and behavioral symptoms, we show % signal change differences as a function of symptom severity, in regions of overlap between the current results and the pre-defined ROIs in the IPS ([Fig. 2](#fig0002){ref-type="fig"}B and C). Additional scatter plots for all clusters of activation, as well as for the left TPJ ROI, are included in the Supplementary Materials section 9[1](#cit_1){ref-type="fn"}.Table 2Table 2Brain regionHemisphereN voxelsMax *Z*-stat*xyz\[rare-No-go minus prevalent-No-go\] activation, negatively correlated with symptom severity***Precuneus, superior parietal cortex, IPS**L16,3184.2-9-6858**Superior frontal gyrus**L83133.6-26072**IPS**R54734.035-4151**Occipito-temporal lobe**L30863.6-52-606**Lateral prefrontal cortex**L30523.7-354515**Middle frontal gyrus**R22233.6385431[^2]

Admittedly, the contrast of rare-No-go with prevalent-No-go overcomes many shortcomings common in the response inhibition literature as discussed earlier, but still contains some possible confounds that are inherent to the design. Specifically, rare-No-go trials are more unexpected than prevalent-No-go trials, and might be eliciting neural responses that are related to expectancy or saliency detection. To distinguish such effects from inhibition-related activations, we conducted an analogous analysis based on Go trials, i.e. examining the interaction of ASRS questionnaire scores with the difference in activation between rare-Go and prevalent-Go. The analysis revealed clusters in bilateral superior frontal gyrus and left inferior frontal gyrus (see detailed results in the Supplementary Materials Section 8) where difference in activation between rare-Go and prevalent-Go were negatively associated with ASRS scores. However, no such activation was seen in the parietal cortex nor in any other regions identified in the No-go trials analysis. These results confirm that the activation observed in the IPS is indeed inhibition-related and not associated with general frequency effects.

### 3.2.3. Functional connectivity: generalized context-dependent psychophysiological interactions {#sec0015}

To further explore the possible underlying mechanisms of response-inhibition we used the right and left IPS activation clusters depicted in [Fig. 2](#fig0002){ref-type="fig"}B, i.e. the intersection of the current whole-brain results with the pre-defined ROIs, as seed-regions for whole-brain gPPI analyses. We were particularly interested in the relationship between the IPS and frontal regions previously suggested to be central to inhibition, including the inferior frontal gyrus and the pre-supplementary motor area ([@bib0004], [@bib0005]; [@bib0015]; [@bib0045]; [@bib0074]), hypothesizing that top-down control from frontal regions may be driving the IPS response to increased inhibitory demand. A whole-brain exploratory analysis with the anterior left IPS seed, including the ASRS symptom scores as a group-level covariate, yielded a cluster of activation in the right inferior frontal gyrus (rIFG), and a cluster in the right primary somatosensory cortex (postcentral gyrus; [Fig. 3](#fig0003){ref-type="fig"}, [Table 3](#tbl0003){ref-type="table"}). When relaxing the statistical threshold, the same cluster in the rIFG emerged also when using the other two seed regions: the right IPS and the posterior left IPS. This finding indicates that the modulation of connectivity between the IPS and the rIFG by the inhibitory demand correlates with the extent of ADHD severity: fronto-parietal connectivity is elevated when response inhibition is challenging (larger for rare-No-go trials than prevalent-No-go trials), but less so for participants reporting high occurrence of ADHD symptoms.Fig. 3gPPI results for a seed region in the left anterior IPS (seed region shown in [Fig. 2](#fig0002){ref-type="fig"}B). Regions in the right IFG and in the right parietal cortex where the modulation of correlation with the IPS seed time course by the inhibitory demand negatively correlated with symptom severity of ADHD.Fig. 3Table 3Table 3Brain regionHemisphereN voxelsMax *Z*-stat*xyz\[rare-No-go minus prevalent-No-go\] interaction with left IPS seed region in gPPI analysis, negatively correlated with symptom severity***IFG**R18223.45922-4**Postcentral gyrus, superior parietal lobule**R17943.3228-3470[^3]

### 3.2.4. Effect of sex, medication status and age {#sec0016}

Follow-up analyses compared inhibition-related activation in male vs. female participants, participants medicated regularly vs. those using psychostimulants sporadically, and investigated the effect of age on inhibition-related activation. None of these analyses yielded significant results.

4. Discussion {#sec0017}
=============

In the present study we aimed to characterize abnormal patterns of brain activation underlying impaired response inhibition in adult participants with ADHD. The novelty of the current study, compared to previous similar attempts, is in applying a unique task design that enables isolation of inhibition-related activation. Contrasting rare-No-go trials with prevalent-No-go trials avoided contamination of the results by visual and motor components that are present in the Go trials. Behaviorally, it was established that adults with ADHD had more difficulty inhibiting responses in the rare-No-go condition than in the prevalent-No-go condition (with more commission errors expressing inhibition failures), confirming a substantial increase in inhibitory demand in this condition. While we have not compared performance between ADHD and controls directly in this study, the rate of commission errors of participants in the rare-No-go condition was 7.6% - higher than that reported for neurotypical adults in the same task (4%, [@bib0040]), which fits with previous reports on deficits in inhibition of a prepotent response in participants with ADHD ([@bib0053]; [@bib0086]; [@bib0090]). Interestingly, although the behavioral effect of No-go trial prevalence was substantial, imaging results indicated no change in parietal responses between rare- and prevalent-No-go conditions. This is in contrast with the pattern of inhibition-related activation in parietal regions that was recently reported in neurotypicals ([@bib0040]).

Importantly, the lack of parietal cortex recruitment is specifically tied to the inhibitory demand: contrasting Go trials from different prevalence yielded extensive brain-wide activations, including in the parietal cortex, but not in the regions of interest in the IPS, demonstrating intact sensitivity to stimulus frequencies. This analysis is also an indication that the lack of IPS recruitment is not a result of increased noise or variability in the ADHD cohort, which would undermine this control analysis.

While we found no differentiated parietal engagement for response inhibition on the group level, using an individual differences approach it was revealed that inhibition-related activation in the parietal cortex (including bilateral IPS) was, in fact, modulated by ADHD symptom severity. Participants who reported moderate ADHD symptoms did show the expected inhibition-related activation (similar to neurotypicals) but this was eliminated in participants who evaluated themselves as experiencing relatively high severity of symptoms. The link between ADHD symptom severity and brain dynamics was further corroborated using a gPPI analysis assessing functional connectivity between the IPS and other brain regions in the context of response inhibition. We found that the similarity of activation time courses between IPS and rIFG, hypothesized to reflect functional connectivity between the two regions, depended on the inhibitory demand and increased with inhibition difficulty, but crucially this effect was compromised with elevated symptom severity of ADHD.

Indeed, the modulation of IPS-IFG functional connectivity by the inhibitory demand fits with theories that highlight the role of the IFG in response inhibition: the IFG is activated in various tasks requiring inhibition ([@bib0010]; [@bib0017]; [@bib0029]; [@bib0065]) and patients with damage to this brain region present behavioral inhibitory failures ([@bib0003]; [@bib0061]). These findings gave rise to the long-standing view of the IFG as a critical locus of response inhibition ([@bib0004], [@bib0005]). In recent years the specificity of the IFG to inhibitory function has been questioned ([@bib0016]; [@bib0030]; [@bib0074]; [@bib0081]), and it has been suggested that the involvement of the IFG in response inhibition tasks results from its role in domain-general fronto-parietal networks that support broader cognitive control functions such as context monitoring ([@bib0006]; [@bib0016]; [@bib0022]; [@bib0031]). In light of this view, and given our findings here and in [@bib0040], we suggest that while the IFG is not specifically engaged in inhibition per se, its function in top-down control is essential in modulating the parietal cortex according to the inhibitory demand to achieve efficient response inhibition. Interestingly, a recent exploratory analysis of parcellation-based functional connectivity of the IFG during a stop-signal task identified the IPS as essential for response inhibition, supporting our current framework ([@bib0056]).

The failure to modulate parietal activation in individuals who report more severe ADHD symptoms may be a consequence of altered responses in the frontal regions, reflecting malfunctioning of cognitive control in general. This is supported by behavioral findings indicating a general deficit in context monitoring, including abnormally effortful task switching deficits ([@bib0014]; [@bib0038]) and lack of sensitivity to temporal regularities ([@bib0025]), and by neuroimaging evidence for hypoactivation of frontal regions, which is well documented in ADHD in a variety of tasks ([@bib0024]; [@bib0026]). Alternatively, lack of parietal modulation in individuals who reported severe ADHD symptoms can stem from abnormal connectivity in fronto-parietal pathways. In this case the identification of the context and the stimuli properties (e.g. novelty, saliency, prevalence) might be intact, but the ability to act upon this information is limited by altered top-down connectivity to other brain regions. This possibility is supported by reports of disrupted functional connectivity in the fronto-parietal cognitive control network in ADHD ([@bib0041]; [@bib0078]), as well as in other neural networks including the default-mode network, the ventral attention network, and motor, saliency, and reward-based networks ([@bib0012]; [@bib0055]). However, hypo-activation and hypo-connectivity are bound together, and our current data cannot tease these possibilities apart.

The current results also demonstrate how individual differences analysis can unravel effects that may be concealed when using only group-averaged statistics. This is especially important in research of ADHD, which is a highly heterogeneous disorder, in its symptomatic manifestation as well as in neuropsychological profiles and in psychopathological pathways ([@bib0013]; [@bib0054]; [@bib0077]; [@bib0085]). Moreover, while current diagnosis is based on a categorical model of ADHD, recent studies support the conceptualization of ADHD as a dimensional phenomenon, that represents a continuum of attentional dysfunction from normal functioning to extreme deficit ([@bib0018]; [@bib0028]; [@bib0066]). The current results highlight the merit of adopting a dimensional experimental design over the traditional comparison of patients with neurotypicals. While group comparison is unquestionably valuable, it suffers at the same time from fundamental pitfalls when clinical groups are involved, primarily its vulnerability to general group differences in variability and in noise (e.g., motion artifacts, structural abnormalities, etc.; [@bib0051]; [@bib0067]). An ideal approach would thus be adopting a fully dimensional design, with a large number of participants that represents the complete range of attentional functioning. In the current study, however, to balance sample size and statistical power with the dimensional approach, and to align with current clinical standards of ADHD definition, we chose to focus on the extremity of the attention spectrum, including only participants with established and rigorous ADHD diagnosis, and analyzing individual differences within this clinical group. The convergence of the whole brain analysis in the clinical group to the same regions of interest in the parietal cortex that were pre-defined from neurotypicals' activation maps provides strong evidence for the contribution of the IPS to response inhibition. Inclusion of participants from across the entire range of attention functioning in future large-scale studies would allow further and wider examination of this hypothesis.

A small number of previous studies focusing on inhibition also used a similar dimensional approach, conducting a whole-brain regression analysis between ADHD symptoms and brain function, but resulted in inconsistent findings ([@bib0019]; [@bib0023]; [@bib0069]). Those studies reported both negative and positive correlations of inhibition-related activation with symptom scores, across a variety of brain regions. However, these studies were based on the classic contrast of No-go or Stop trials versus Go trials. This contrast might include activation that is unrelated to inhibition per se, but is a consequence of motor, visual and/or perceptual processes that distinguish No-go from Go events. As such, it might also depend heavily on the specific stimuli used in a certain study, and on factors other than response inhibition that may be associated with the syndrome, all of which may contribute to the inconsistencies among studies. Consequently, the current results cannot be directly compared to these previous reports, due to the fundamental difference in the contrasts of interest.

One factor that has been previously suggested to impact inhibition-related activation in adults with ADHD is medication status. Current psychostimulants treatment as well as the history of medication usage has been associated with the neural substrates of inhibition ([@bib0019]). While studies in children and youth with ADHD show that acute administration of psychostimulants is linked with increased stopping-related activation and even normalization of the signal to the level of neurotypicals, there is no conclusive evidence regarding long-term effects ([@bib0062]; [@bib0070]), and there is only one report of such effects in adults ([@bib0009]; [@bib0062]). In the current study all of the participants had a history of psychostimulants usage, and most of them were currently treated. Thus, we could not directly address the effect of long-term medication. However, when comparing participants reporting regular usage of psychostimulants with participants reporting occasional usage of psychostimulants, no differences were found in inhibition-related activation. Future research is needed to inspect whether medication-naïve participants show similar effects to those reported in the current study.

To conclude, our findings whereby IPS engagement in response inhibition scales with symptom severity, point to this signal\'s potential usefulness as a neuromarker of ADHD in adults and as a target for intervention. The fact that fronto-parietal connectivity was similarly sensitive to individual differences in symptom severity highlight the two possible sources of this pattern of results -- frontal hypoactivation (possibly associated with reduced context sensitivity) or fronto-parietal disconnection (possibly leading to impaired ability to act upon the changing context). Both frontal activation and brain-wide connectivity patterns can be effected by pharmacological intervention ([@bib0064]; [@bib0068]; [@bib0079]), and as recently shown, also by neurofeedback training ([@bib0001]; [@bib0063]). Thus, future research can test whether normalization of IFG responses would extend to normalization in IPS-IFG connectivity and/or can lead to enhanced IPS modulation during response inhibition, and whether such neural effects would be associated with changes in symptom severity and other aspects of everyday functioning. Targeting individual differences in such intervention studies can increase the impact and therapeutic value of such programs.

The current approach and findings could also be relevant to other disorders associated with response inhibition abnormalities, such as psychosis, schizophrenia, anxiety and obsessive-compulsive disorders, where a similar framework can be used to examine the underlying neural mechanisms of impaired response inhibition on a group and individual levels.
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Image, application 1

Note that the scatter plots are for visualization only, while statistical inference is relying on the whole-brain analysis. While the reader might be inclined to look for correlation values accompanying this type of scatterplots, computing any inferential correlational statistics in this case is misleading, since the selection of regions was based on the same data rendering the analyses non-independent. As demonstrated and discussed at length by Vul and colleagues, reporting correlation values in this situation of a non-independent analysis results in biased and inflated numbers ([@bib0058]; [@bib0059]; [@bib0084]).

Supplementary material associated with this article can be found, in the online version, at [doi:10.1016/j.nicl.2019.102119](https://doi.org/10.1016/j.nicl.2019.102119){#interref0003}.

[^1]: Percent signal change for each condition was computed in reference to an implicit baseline and averaged across voxels within each ROI. BF~null~ = Bayes Factor in favor of the null hypothesis, i.e. no difference between conditions. IPS = intraparietal sulcus; TPJ = temporoparietal junction.

[^2]: N Voxels: number of activated voxels per cluster; Max *Z*-stat: maximum *z*-statistic for each cluster; *x*, *y*, and *z* are MNI coordinates for peak of each cluster. R = right; L = left. IPS = intraparietal sulcus.

[^3]: N Voxels: number of activated voxels per cluster; Max *Z*-stat: maximum *z*-statistic for each cluster; *x*, *y*, and *z* are MNI coordinates for peak of each cluster. R = right; L = left. IFG = inferior frontal gyrus.
